NASDAQ:BMRA Biomerica Q2 2026 Earnings Results & Report $1.83 -0.06 (-3.17%) As of 10/9/2026 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Biomerica reported Q2 2026 earnings on January 14, 2026. The company reported EPS of -$0.45, while revenue was $1.21 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateJanuary 14, 2026TimeAfter Market Closes Biomerica EPS ResultsActual EPS-$0.45Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABiomerica Revenue ResultsActual Revenue$1.21 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsBiomerica's next earnings date is estimated for Wednesday, October 21, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Biomerica Q2 2026 Earnings FAQ Did Biomerica beat earnings estimates for Q2 2026? Biomerica (NASDAQ:BMRA) reported earnings of -$0.45 per share for Q2 2026. The report was announced on Wednesday, January 14, 2026. What was Biomerica's revenue for Q2 2026? Biomerica reported revenue of $1.21 million for Q2 2026. When is Biomerica's next earnings date? Biomerica's next earnings date is estimated for Wednesday, October 21, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biomerica on the company's earnings history page. Biomerica Earnings HeadlinesBiomerica (NASDAQ:BMRA) Shares Break Below Two Hundred Day Moving Average - Should You Sell?October 9 at 3:23 AM | americanbankingnews.comBiomerica (NASDAQ:BMRA) versus Boston Scientific (NYSE:BSX) Head-To-Head ContrastOctober 2, 2026 | americanbankingnews.comThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO as soon as this fall. TradeSmith CEO Keith Kaplan says chasing the next hot IPO isn't necessary. His AI-driven system, built on a platform pioneered by Google, ranks every stock in the S&P 500 and narrows the list to just five names to hold each month. Backtests show the Top Five Stocks outperformed the S&P 500 by 4x in August alone.October 10 at 1:00 AM | TradeSmith (Ad)Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Decline in Short InterestOctober 1, 2026 | americanbankingnews.comBiomerica Files $250 Million Mixed ShelfSeptember 27, 2026 | finance.yahoo.comBiomerica Posts Narrower Q4 Loss On Higher Sales; Stock DownSeptember 2, 2026 | rttnews.comSee More Biomerica Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Biomerica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biomerica and other key companies, straight to your email. Email Address About BiomericaBiomerica (NASDAQ:BMRA) is a medical diagnostics company that develops and commercializes products designed to help diagnose and manage gastrointestinal and other health conditions. The company focuses on tests and related solutions intended to support more personalized treatment decisions. Biomerica’s best-known product platform is inFoods, which uses blood-based testing to identify foods that may contribute to symptoms associated with gastrointestinal disorders. The company has emphasized inFoods IBS, a diagnostic-guided dietary management solution for people with irritable bowel syndrome, pairing test results with individualized food recommendations. Biomerica also has developed and marketed diagnostic products for conditions including Helicobacter pylori infection, allergies and respiratory illnesses. Its products have been distributed through healthcare providers and commercial partners in the United States and select international markets. The company is headquartered in Irvine, California, and has been led by Chief Executive Officer Zackary Irani.View Biomerica ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
